FrancophonIA/ELRC3.0 huggingface dataset:
English: Clinical trials, which have included gradual dose reduction at the end of treatment, have found that 30% of patients developed symptoms following discontinuation of treatment with paroxetine compared to 20% among those stopping placebo.
Slovenian: V kliničnih preskušanjih, kjer so ob koncu zdravljenja postopoma nižali odmerke, so ugotovili, da so se pri 30 % bolnikov po ukinitvi zdravljenja s paroksetinom pojavili simptomi v primerjavi z 20 % tistih, ki so prejemali placebo.
English: Partial saturation of the first-pass effect and reduced plasma clearance occur as the body burden increases with higher single doses or on multiple dosing.
Slovenian: Ob obremenitvi telesa z večjim enkratnim odmerkom ali z več odmerki pride do delne zasičenosti učinka prvega prehoda in do zmanjšanega plazemskega očistka.
English: In some patients, with insufficient response to 20 mg, the dose may be increased gradually up to a maximum of 50 mg a day in 10 mg steps according to the patient's response.
Slovenian: Pri nekaterih bolnikih z nezadostnim odzivom na zdravljenje z 20 mg odmerkom lahko v skladu z bolnikovim odzivom odmerek postopno povečujemo za 10 mg, vendar le do največjega odmerka 50 mg na dan.
English: The hyponatraemia generally reverses on discontinuation of paroxetine.
Slovenian: Hiponatriemija običajno po prekinitvi zdravljenja s paroksetinom preneha.
English: Box 158, Skoyen, N-0212 Oslo, Norway
Slovenian: Alpharma AS, P.O. Box 158, Skoyen, N-0212 Oslo, Norway
English: Dizziness, sensory disturbances (including paraesthesia and electric shock sensations), sleep disturbances (including intense dreams), agitation or anxiety, nausea, tremor, confusion, sweating, headache, diarrhoea, palpitations, emotional instability, irritability, and visual disturbances have been reported.
Slovenian: Poročali so o omotici, senzoričnih motnjah (vključno s parestezijo in občutki električnega šoka), motnjah spanja (vključno z intenzivnimi sanjami), agitaciji ali anksioznosti, navzei, tremorju, zmedenosti, znojenju, glavobolu, driski, palpitacijah, čustveni labilnosti, razdražljivosti in motnjah vida.
English: If after some weeks on the recommended dose insufficient response is seen some patients may benefit from having their dose increased gradually up to a maximum of 60 mg/day.
Slovenian: Če se po nekaj tednih zdravljenja s priporočenim odmerkom ne opazi zadosten odziv lahko nekaterim bolnikom koristi, če odmerek postopno povečujemo do največjega odmerka 60 mg/dan.
English: Denmark 1A Farma A/S Herstedøstervej 27-29
Slovenian: 1A Farma A/S Herstedøstervej 27-29 2620 Albertslund Denmark
English: Neonates should be observed if maternal use of paroxetine continues into the later stages of pregnancy, particularly the third trimester.
Slovenian: Če je mati paroksetin uporabljala med pozno nosečnostjo, še posebno med tretjim trimesečjem, je potrebno novorojence opazovati.
English: Patients with panic disorder should be treated for a sufficient period to ensure that they are free from symptoms.
Slovenian: Za zagotovilo, da so bolniki s panično motnjo brez simptomov jih je potrebno zdraviti dovolj dolgo.
English: Post-marketing reports of hepatic events (such as hepatitis, sometimes associated with jaundice and/or liver failure) have also been received very rarely.
Slovenian: V poročilih, pridobljenih po pridobitvi dovoljenja za promet so zelo redko poročali o jetrnih primerih (kot so hepatitis, včasih povezan z zlatenico in/ali odpovedjo jeter).
English: Uncommon: skin rashes, pruritus Very rare: photosensitivity reactions.
Slovenian: Bolezni kože in podkožja Pogosti: znojenje Občasni: kožni izpuščaji, srbenje Zelo redki: fotosenzitivne reakcije
English: The efficacy of paroxetine in treating major depression in adults is established and supported by numerous short and long-term trials.
Slovenian: Učinkovitost paroksetina pri zdravljenju velike depresije pri odraslih ugotavljajo in potrjujejo številna kratkotrajna in dolgotrajna preskušanja.
English: This lack of interaction with post-synaptic receptors in vitro is substantiated by in vivo studies which demonstrate lack of CNS depressant and hypotensive properties.
Slovenian: Šibko medsebojno učinkovanje s postsinaptičnimi receptorji in vitro potrjujejo tudi in vivo študije, ki kažejo odsotnost sedativnih lastnosti v centralnem živčnem sistemu in hipotenzivnih lastnosti.
English: Caution is advised in patients taking SSRI's concomitantly with oral anticoagulants, drugs known to affect platelet function or other drugs that may increase risk of bleeding (e.g. atypical antipsychotics such as clozapine, phenothiazines, most TCA's, acetylsalicylic acid, NSAID's, COX-2 inhibitors) as well as in patients with a history of bleeding disorders or conditions which may predispose to bleeding.
Slovenian: Previdnost je priporočena tako pri bolnikih, ki sočasno s selektivnimi zaviralci prevzema serotonina jemljejo peroralne antitrombotike, zdravila za katera je znano da vplivajo na funkcijo trombocitov ali druga zdravila, ki lahko povečajo tveganje za krvavitve (npr. atipični antipsihotiki kot so klozapin, fenotiazini, večina tricikličnih antidepresivov, acetilsalicilna kislina, nesteroidna protivnetna zdravila, zaviralci ciklooksigenaze tipa 2), kot tudi pri bolnikih, ki imajo v anamnezi motnje hemostaze ali bolezni, ki so lahko predispozicija za krvavitve.
English: Cardiac disorders Uncommon: sinus tachycardia.
Slovenian: Srčne bolezni Občasni: sinusna tahikardija Redki: bradikardija
English: At least one week should elapse between discontinuation of paroxetine and initiation of therapy with any MAOI.
Slovenian: Med ukinitvijo paroksetina in pričetkom zdravljenja s katerim koli zaviralcem monoaminooksidaz mora miniti vsaj en teden.
English: Skøyen, 0212 Oslo Norge
Slovenian: Alpharma AS Harbitzalléen 3 Skøyen, 0212 Oslo Norge
English: Luxembourg GlaxoSmithKline s.a./n.v.
Slovenian: Luksemburg GlaxoSmithKline s.a./n.v.
English: Generalised Anxiety Disorder
Slovenian: GENERALIZIRANA ANKSIOZNA MOTNJA
English: The most commonly reported adverse events are dizziness, sensory disturbances, sleep disturbances, anxiety and headache.
Slovenian: Najpogosteje poročani neželeni učinki so omotica, motnje zaznavanja, motnje spanja, občutek tesnobe in glavobol.
English: No initial dosage adjustment is considered necessary when the drug is to be co-administered with known drug metabolising enzyme inducers (e.g. carbamazepine, rifampicin, phenobarbital, phenytoin).
Slovenian: Ocenjuje se, da pri sočasni uporabi znanih induktorjev encima, ki presnavlja zdravilo (npr. karbamazepin, rifampicin, fenobarbital, fenitoin) začetnega odmerka ni potrebno prilagoditi.
English: WITHDRAWAL SYMPTOMS SEEN ON DISCONTINUATION OF PAROXETINE Abrupt discontinuation should be avoided (see section 4.4 Special Warnings and Special Precautions for Use and section 4.8 Undesirable Effects).
Slovenian: Nenadni prekinitvi zdravljenja se je potrebno izogibati (glejte poglavje 4.4 Posebna opozorila in previdnostni ukrepi ter poglavje 4.8 Neželeni učinki).
English: Events such as coma or ECG changes have occasionally been reported and, very rarely with a fatal outcome, but generally when paroxetine was taken in conjunction with other psychotropic drugs, with or without alcohol.
Slovenian: Občasno so poročali o komi ali spremembah EKG vendar zelo redko s smrtnim izidom.
English: Symptoms such as respiratory distress, cyanosis, apnoea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycaemia, hypertonia, hypotonia, hyperreflexia, tremor, jitteriness, irritability, lethargy, constant crying, somnolence and difficulty in sleeping may occur.
Slovenian: Pojavijo se lahko simptomi, kot so dihalna stiska, cianoza, apneja, krči, nestabilna temperatura, težave pri hranjenju, bruhanje, hipoglikemija, hipertonija, hipotonija, hiperrefleksija, tresenje, živčnost, razdražljivost, letargija, stalen jok, zaspanost in motnje spanja.
English: Panic Disorder
Slovenian: Panična motnja
English: In patients with diabetes, treatment with an SSRI may alter glycaemic control.
Slovenian: Pri bolnikih s sladkorno boleznijo lahko zdravljenje s selektivnim zaviralcem prevzema serotonina spremeni urejenost sladkorne bolezni.
English: A wide margin of safety is evident from available overdose information on paroxetine.
Slovenian: Glede na dostopne podatke o prevelikem odmerjanju paroksetina je očiten njegov varnostni profil.
English: Rua Alfredo da Silva, 3-C, P-1300-040 Lisboa Portugal
Slovenian: Portugalska Merck S.A, Rua Alfredo da Silva, 3-C, P-1300-040 Lisboa Portugal
English: Denmark Scand Pharm Generics AB Ynglingagatan 14, 5tr
Slovenian: Scand Pharm Generics AB Ynglingagatan 14, 5tr S-11347 Stockholm Sweden
English: The following symptoms may occur in the neonate after maternal paroxetine use in later stages of pregnancy: respiratory distress, cyanosis, apnoea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycaemia, hypertonia, hypotonia, hyperreflexia, tremor, jitteriness, irritability, lethargy, constant crying, somnolence and difficulty in sleeping .
Slovenian: Če je mati uporabljala paroksetin med pozno nosečnostjo se pri novorojencu lahko pojavijo naslednji simptomi: respiratorni distres, cianoza, apneja, epileptični napadi, nihanje telesne temperature, težave pri hranjenju, bruhanje, hipoglikemija, hipotonija, hipertonija, hiperrefleksija, tremor, nervoznost, razdražljivost, letargija, somnolenca, neprestano jokanje in težave s spanjem.
English: IIP-Institut für industrielle Pharmazie F&E GmbH Benzstraße 2a D-63741 Aschaffenburg Germany
Slovenian: Madžarska IIP-Institut für industrielle Pharmazie F&E GmbH Benzstraße 2a
English: In clinical trials adverse events seen on treatment discontinuation occurred in 30% of patients treated with paroxetine compared to 20% of patients treated with placebo.
Slovenian: V kliničnih preskušanjih so se neželeni učinki ob ukinitvi zdravljenja pojavljali pri 30 % bolnikov, zdravljenih s paroksetinom, v primerjavi z 20 % bolnikov, ki so prejemali placebo.
English: 5.1 Pharmacodynamic Properties
Slovenian: 5.1 Farmakodinamične lastnosti
English: If after some weeks on the recommended dose insufficient response is seen some patients may benefit from having their dose increased gradually in 10 mg steps up to a maximum of 50 mg/day.
Slovenian: Če se po nekaj tednih zdravljenja s priporočenim odmerkom ne opazi zadosten odziv lahko nekaterim bolnikom koristi, če jim odmerek postopno povečujemo za 10 mg, vendar le do največjega odmerka 50 mg/dan.
English: I.C.C.
Slovenian: Nizozemska I.C.C.
English: Insufficient evidence has been made available concerning the efficacy of paroxetine in this population for the treatment of obsessive compulsive disorder and social anxiety/social phobia.
Slovenian: Pri tej populaciji glede učinkovitosti paroksetina za zdravljenje obsesivno kompulzivne motnje in socialne anksioznosti/socialne fobije ni na voljo zadostnih podatkov.
English: Some of the adverse drug reactions listed below may decrease in intensity and frequency with continued treatment and do not generally lead to cessation of therapy.
Slovenian: Intenzivnost in pogostnost nekaterih neželenih učinkov, ki so navedeni spodaj, se lahko tekom neprekinjenega zdravljenja zmanjšata.
English: Uncommon: extrapyramidal disorders
Slovenian: Občasni: ekstrapiramidne motnje
English: Rua Prof. Henrique de Barros Edifício Sagres, 3° A 2685-338 Prior Velho
Slovenian: Rua Prof. Henrique de Barros Edifício Sagres, 3°
English: Caution should be advised and a closer clinical monitoring is required when these drugs are combined with paroxetine.
Slovenian: V primeru uporabe teh zdravil v kombinaciji s paroksetinom svetujemo previdnost in temeljitejši klinični nadzor.
English: 20 mg/10 ml Oral suspension
Slovenian: 20 mg/10 ml Peroralna suspenzija Peroralna uporaba
English: MOM Park Gesztenyés torony Hungary
Slovenian: Gesztenyés torony
English: Elderly and Renal/Hepatic Impairment
Slovenian: Starostniki in bolniki z ledvično/jetrno okvaro
English: Patients have generally recovered without serious sequelae even when doses of up to 2000 mg have been taken alone.
Slovenian: Če so bolniki vzeli odmerek do 2000 mg (brez kombinacije z drugimi zdravili) so običajno okrevali brez resnih posledic.
English: As with other SSRI's, paroxetine infrequently causes mydriasis and should be used with caution in patients with narrow angle glaucoma or history of glaucoma.
Slovenian: Tako kot drugi selektivni zaviralci prevzema serotonina tudi paroksetin povzroča midriazo, sicer redko, vendar pa ga je pri bolnikih z ozkokotnim glavkomom ali bolnikih z glavkomom v anamnezi potrebno uporabljati previdno.
English: Denmark PharmaCoDane Aps Marielundvej 46 A
Slovenian: PharmaCoDane Aps Marielundvej 46 A 2730 Herlev Denmark
English: The long-term efficacy of paroxetine in depression has been demonstrated in a 52 week maintenance study with relapse prevention design: 12% of patients receiving paroxetine (20-40mg daily) relapsed, versus 28% of patients on placebo.
Slovenian: Dolgoročno učinkovitost paroksetina pri depresiji so dokazali v 52-tedenski vzdrževalni študiji z zasnovo preprečevanja relapsov: 12 % bolnikov, ki so prejemali paroksetin (20-40 mg dnevno), je doživelo relaps v primerjavi z 28 % bolnikov, ki so prejemali placebo.
English: Major Depressive Episode Obsessive Compulsive Disorder Panic Disorder with and without agoraphobia Social Anxiety Disorders/Social phobia Generalised Anxiety Disorder Post-traumatic Stress Disorder
Slovenian: Zdravljenje: hude depresivne epizode obsesivno-kompulzivne motnje panične motnje z ali brez agorafobije socialne anksiozne motnje/socialne fobije generalizirane anksiozne motnje posttravmatske stresne motnje
English: Insufficient evidence has been made available concerning the efficacy of paroxetine for the treatment of obsessive compulsive disorder and social anxiety/social phobia.
Slovenian: Glede učinkovitosti paroksetina pri zdravljenju obsesivno kompulzivne motnje in socialne anksioznosti/socialne fobije ni na voljo zadostnih podatkov.
English: Respiratory, thoracic and mediastinal disorders Common: yawning.
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora Pogosti: zehanje
English: Slovac Republic ratiopharm GmbH Gras-Orco-Strasse 3 89079 Ulm
Slovenian: Slovaška ratiopharm GmbH Gras-Orco-Strasse 3 89079 Ulm
English: (see section 4.4 Special warnings and Special Precautions for use) Caution is advised in patients taking SSRI's, concomitantly with oral anticoagulants, drugs known to affect platelet function or increase risk of bleeding (e.g. atypical antipsychotics such as clozapine, phenothiazines, most TCA's, acetylsalicylic acid, NSAID's, COX-2 inhibitors) as well as in patients with a history of bleeding disorders or conditions which may predispose to bleeding.
Slovenian: Previdnost priporočamo tako pri bolnikih, ki sočasno s selektivnimi zaviralci prevzema serotonina jemljejo peroralne antitrombotike, zdravila za katera je znano da vplivajo na funkcijo trombocitov ali povečajo tveganje za krvavitve (npr. atipični antipsihotiki kot so klozapin, fenotiazini, večina tricikličnih antidepresivov, acetilsalicilna kislina, nesteroidna protivnetna zdravila, zaviralci ciklooksigenaze tipa 2), kot tudi pri bolnikih, ki imajo v anamnezi motnje hemostaze ali bolezni, ki so lahko predispozicija za krvavitve.
English: There is a possibility of an increased risk of suicide related behaviour in young adults ages 18-29.
Slovenian: Pri mlajših odraslih, starih od 18-29 let je tveganje za samomorilno vedenje lahko večje.
English: Very rare: serotonin syndrome (symptoms may include agitation, confusion, diaphoresis, hallucinations, hyperreflexia, myoclonus, shivering, tachycardia and tremor).
Slovenian: Zelo redki: serotoninski sindrom (simptomi lahko vključujejo agitacijo, zmedenost, čezmerno znojenje, halucinacije, hiperrefleksijo, mioklonus, drgetanje, tahikardijo in tremor) O ekstrapiramidnih motnjah vključno z orofacialno distonijo so poročali pri bolnikih, pri katerih so bile že predhodno prisotne motnje gibanja ali pri tistih, ki so bili zdravljeni z nevroleptiki.
English: The long-term efficacy of paroxetine in treating panic disorder has been demonstrated in a 24 week maintenance study with relapse prevention design: 5% of patients receiving paroxetine (10-40mg daily) relapsed, versus 30% of patients on placebo.
Slovenian: Dolgoročno učinkovitost paroksetina pri zdravljenju panične motnje so pokazali v 24tedenski vzdrževalni študiji z zasnovo preprečevanja relapsa: 5 % bolnikov, ki so prejemali paroksetin (10-40 mg dnevno), je doživelo relaps v primerjavi s 30 % bolnikov, ki so prejemali placebo.
English: Paroxetine is a potent and selective inhibitor of 5-hydroxytryptamine (5-HT, serotonin) uptake and its antidepressant action and effectiveness in the treatment of OCD, Social Anxiety disorder/Social Phobia, General Anxiety Disorder, Post-traumatic Stress Disorder and Panic Disorder is thought to be related to its specific inhibition of 5-HT uptake in brain neurones.
Slovenian: Domnevno je njegovo antidepresivno delovanje in učinkovitost pri zdravljenju obsesivnokompulzivne motnje, socialne anksiozne motnje/socialne fobije, generalizirane anksiozne motnje, posttravmatske stresne motnje in panične motnje povezano z njegovim specifičnim zaviranjem prevzema serotonina v možganskih nevronih.
English: The long-term efficacy of paroxetine in treating panic disorder was demonstrated in a 24 week maintenance study with relapse prevention design: 5% of patients receiving paroxetine (10-40mg daily) relapsed, versus 30% of patients on placebo.
Slovenian: Dolgoročna učinkovitost paroksetina pri zdravljenju panične motnje je bila dokazana s 24-tedensko vzdrževalno študijo, ki je bila zasnovana tako, da je preprečevala relapse: do relapsa je prišlo pri 5 % bolnikov, ki so prejemali paroksetin (10-40 mg dnevno) oziroma pri 30 % bolnikov, ki so prejemali placebo.
English: A pharmacodynamic interaction between paroxetine and oral anticoagulants may occur.
Slovenian: Med paroksetinom in peroralnimi antitrombotiki lahko pride do farmakodinamične interakcije.
English: Sandoz GmbH Biochemiestraße 10, A-6250 Kundl Austria
Slovenian: Sandoz GmbH Biochemiestrasse 10 A-6250 Kundl Austria
English: Moreover, patients are likely to experience improved sleep as they respond to paroxetine therapy.
Slovenian: Pri bolnikih, ki so se odzvali na zdravljenje s paroksetinom, se lahko spanje celo izboljša.
English: The occurrence of withdrawal symptoms is not the same as the drug being addictive or dependence producing.
Slovenian: Zaradi navajenosti na zdravilo ali odvisnosti pa pojavnost odtegnitvenih simptomov ni ista.
English: On the basis of the assessed data the CHMP concluded that paroxetine is effective in the treatment of major depressive episode, obsessive compulsive disorder, panic disorder with and without agarophobia, social anxiety disorder/social phobia, generalised anxiety disorder and post-traumatic stress disorder.
Slovenian: Na podlagi ocenjenih podatkov so v CHMP zaključili, da je paroksetin učinkovit pri zdravljenju velike depresivne epizode, obsesivno kompulzivne motnje, panične motnje z agorafobijo ali brez nje, motnje socialne anksioznosti/socialne fobije, motnje generalizirane anksioznosti in posttravmatske stresne motnje.
English: - The Committee, as a consequence, considered the benefit/risk balance of paroxetine containing medicinal products to be favourable in the treatment of major depressive episode, obsessive compulsive disorder, panic disorder with and without agarophobia, social anxiety disorder/social phobia, generalised anxiety disorder and post-traumatic stress disorder in adults.
Slovenian: - je Odbor posledično upošteval, da je razmerje koristi in tveganj zdravil, vsebujočih paroksetin, pri zdravljenju velike depresivne epizode, obsesivno kompulzivne motnje, panične motnje z agorafobijo in brez nje, motnje socialne anksioznosti/socialne fobije, generalizirane anksiozne motnje in posttravmatske stresne motnje pri odraslih ugodno.
English: Neuraxpharm Arzneimittel GmbH & Co. KG
Slovenian: Neuraxpharm Arzneimittel GmbH & Co.
English: Regarding efficacy, the CHMP concluded that paroxetine is effective in the treatment of major depressive episode, obsessive compulsive disorder, panic disorder with and without agarophobia, social anxiety disorder/social phobia, generalised anxiety disorder and post-traumatic stress disorder in adults.
Slovenian: Glede učinkovitosti so v CHMP zaključili, da je paroksetin učinkovit pri zdravljenju velike depresivne epizode, obsesivno kompulzivne motnje, panične motnje z agorafobijo in brez nje, motnje socialne anksioznosti/socialne fobije, motnje generalizirane anksioznosti ter posttravmatske stresne motnje pri odraslih.
English: Very rare: gastrointestinal bleeding.
Slovenian: Zelo pogosti: navzea Pogosti: konstipacija, driska, suha usta Zelo redki: gastrointestinalne krvavitve
English: The efficacy of paroxetine in the treatment of social anxiety disorders in adults was investigated in some short-term and long-term studies.
Slovenian: Učinkovitost paroksetina pri zdravljenju motenj socialne anksioznosti pri odraslih so preiskovali v nekaterih kratkotrajnih in dolgotrajnih študijah.
English: Pharma GmbH & Co. KG Leipziger Str. 7-13
Slovenian: KG Leipziger Str. 7-13
English: As with all antidepressants, paroxetine should be used with caution in patients with a history of mania.
Slovenian: Pri bolnikih z manijo v anamnezi je potrebno, tako kot vse antidepresive, tudi paroksetin uporabljati previdno.
English: CYP2D6 inhibitory potency of paroxetine
Slovenian: Paroksetin kot zaviralec CYP2D6
English: Medochemie Ltd P.O.
Slovenian: Pharmascope Ltd.
English: A discussion on the safety of paroxetine containing medicinal products took place in CHMP based on the Rapporteur´s and Co-Rapporteur´s Assessment Reports and the data presented by the MAHs.
Slovenian: V CHMP so na podlagi poročil Rapporteur´s in Co-Rapporteur´s Assessment Reports in podatkov, ki so jih predstavili imetniki dovoljenj za promet z zdravilom (Marketing Authorisation Holders, MAHs), razpravljali o varnosti zdravil, vsebujočih paroksetin.
English: • Renal/hepatic impairment
Slovenian: • Ledvična/jetrna okvara
English: - The Committee considered that paroxetine containing medicinal products are effective in the treatment of major depressive episode, obsessive compulsive disorder, panic disorder with and without agarophobia, social anxiety disorder/social phobia, generalised anxiety disorder and post-traumatic stress disorder in adults.
Slovenian: - je Odbor upošteval, da so zdravila, vsebujoča paroksetin, učinkovita pri zdravljenju velike depresivne epizode, obsesivno kompulzivne motnje, panične motnje z agorafobijo in brez nje, motnje socialne anksioznosti/socialne fobije, motnje generalizirane anksioznosti in posttravmatske stresne motnje pri odraslih.
English: Reproductive system and breast disorders Very common: sexual dysfunction.
Slovenian: Motnje reprodukcije in dojk Zelo pogosti: spolne motnje Redki: hiperprolaktinemija/galaktoreja Zelo redki: priapizem
English: The efficacy of paroxetine in the treatment of panic disorders in adults was investigated in some shortterm and long-term studies.
Slovenian: Učinkovitost paroksetina pri zdravljenju paničnih motenj pri odraslih so raziskovali v nekaterih kratkotrajnih in dolgotrajnih študijah.
English: Poland ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm, Germany
Slovenian: Poljska ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm, Germany
English: Oral anticoagulants
Slovenian: Peroralni antitrombotiki
English: Results from observational studies indicate no increased risk of suicidality in patients who were prescribed paroxetine and likewise, post marketing reports indicate low rates of suicidal related behaviours.
Slovenian: Podatki iz opazovalnih študij ne kažejo na povečano tveganje za samomorilnost pri bolnikih, ki jemljejo paroksetin.
English: The efficacy of paroxetine in the treatment of PTSD in adults was investigated in some short-term and long-term studies.
Slovenian: Učinkovitost paroksetina pri zdravljenju PTSD pri odraslih so raziskovali v nekaterih kratkotrajnih in dolgotrajnih študijah.